Pharming Group (PHGUF) Short Interest Ratio & Short Volume → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free PHGUF Stock Alerts $0.95 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Pharming Group Short Interest DataCurrent Short Volume1,986,400 sharesPrevious Short Volume2,163,800 sharesChange Vs. Previous Month-8.20%Dollar Volume Sold Short$2.12 millionShort Interest Ratio / Days to Cover4,966.0Last Record DateApril 15, 2024Outstanding Shares652,410,000 sharesPercentage of Shares Shorted0.30%Today's Trading Volume0 sharesAverage Trading Volume194 sharesToday's Volume Vs. Average0% Short Selling Pharming Group ? Sign up to receive the latest short interest report for Pharming Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPHGUF Short Interest Over TimePHGUF Days to Cover Over TimePHGUF Percentage of Float Shorted Over Time Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. Pharming Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,986,400 shares $2.12 million -8.2%N/A4966 $1.07 3/31/20242,163,800 shares $2.60 million +4.4%N/A0 $1.20 3/15/20242,072,400 shares $2.49 million -4.8%N/A767.6 $1.20 2/29/20242,177,000 shares $2.55 million +2.7%N/A21770 $1.17 2/15/20242,120,700 shares $2.48 million -8.7%N/A5301.8 $1.17 1/15/20243,254,500 shares $3.82 million -50.8%N/A0 $1.18 Get the Latest News and Ratings for PHGUF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter. 12/31/20236,614,000 shares $7.77 million -15.1%N/A0 $1.18 12/15/20237,786,400 shares $9.15 million -0.6%N/A9733 $1.18 11/30/20237,831,200 shares $8.93 million +17.2%N/A78312 $1.14 11/15/20236,680,500 shares $7.62 million -8.0%N/A0 $1.14 10/31/20237,262,800 shares $8.28 million -6.8%N/A0 $1.14 10/15/20237,788,600 shares $8.88 million -5.7%N/A217.6 $1.14 9/30/20238,261,900 shares $10.74 million -6.9%N/A82619 $1.30 9/15/20238,875,400 shares $10.92 million -0.3%N/A4930.8 $1.23 8/31/20238,902,400 shares $11.04 million +7.8%N/A0 $1.24 8/15/20238,257,600 shares $10.24 million -0.7%N/A0 $1.24 7/31/20238,317,200 shares $10.31 million -4.0%N/A20793 $1.24 7/15/20238,662,600 shares $10.74 million -4.0%N/A2406.3 $1.24 6/30/20239,018,400 shares $10.60 million +2.1%N/A90184 $1.18 6/15/20238,833,300 shares $10.86 million +12.3%N/A2103.2 $1.23 5/31/20237,867,900 shares $9.44 million +5.8%N/A26226.3 $1.20 5/15/20237,437,900 shares $8.70 million +15.2%N/A74379 $1.17 4/30/20236,456,400 shares $7.04 million +38.0%N/A64564 $1.09 4/15/20234,679,100 shares $5.43 million +22.8%N/A3899.3 $1.16 3/31/20233,809,300 shares $4.80 million +17.9%N/A1029.5 $1.26 3/15/20233,231,000 shares $3.72 million +19.2%N/A4038.8 $1.15 2/28/20232,709,800 shares $3.07 million -16.4%N/A6774.5 $1.13 2/15/20233,240,100 shares $4.37 million -27.9%N/A3240.1 $1.35 1/31/20234,490,500 shares $6.42 million +1.2%N/A2041.1 $1.43 1/15/20234,437,200 shares $5.64 million +0.5%N/A11093 $1.27 12/30/20224,416,300 shares $5.08 million -0.5%N/A1577.3 $1.15 12/15/20224,436,400 shares $5.23 million +0.0%N/A2334.9 $1.18 11/30/20224,435,700 shares $5.37 million -6.7%N/A44357 $1.21 11/15/20224,756,400 shares $5.23 million +5.3%N/A15854.7 $1.10 10/31/20224,515,900 shares $4.43 million -4.9%N/A45159 $0.98 10/15/20224,748,300 shares $4.91 million -8.1%N/A47483 $1.04 9/30/20225,164,800 shares $5.55 million +23.2%N/A2582.4 $1.08 9/15/20224,191,000 shares $4.86 million +0.7%N/A530.5 $1.16 8/31/20224,162,700 shares $4.87 million -1.4%N/A1892.1 $1.17 8/15/20224,222,800 shares $4.14 million +250.6%N/A391 $0.98The Department of Defense Has a New Drone Contractor (Ad)The Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest PHGUF Short Interest - Frequently Asked Questions What is Pharming Group's current short interest? Short interest is the volume of Pharming Group shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,986,400 shares of PHGUF short. Learn More on Pharming Group's current short interest. What is a good short interest ratio for Pharming Group? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PHGUF shares currently have a short interest ratio of 4,966.0. Learn More on Pharming Group's short interest ratio. Is Pharming Group's short interest increasing or decreasing? Pharming Group saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 1,986,400 shares, a decrease of 8.2% from the previous total of 2,163,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pharming Group's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Pharming Group: ORIC Pharmaceuticals, Inc. (13.97%), Mineralys Therapeutics, Inc. (3.77%), Aerovate Therapeutics, Inc. (7.15%), Silence Therapeutics plc (0.49%), Stoke Therapeutics, Inc. (10.61%), Lyell Immunopharma, Inc. (15.48%), Nurix Therapeutics, Inc. (14.32%), Calliditas Therapeutics AB (publ) (0.02%), CureVac (4.57%), GH Research PLC (4.95%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Pharming Group stock? Short selling PHGUF is an investing strategy that aims to generate trading profit from Pharming Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharming Group? A short squeeze for Pharming Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PHGUF, which in turn drives the price of the stock up even further. How often is Pharming Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PHGUF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ORIC Short Interest Data MLYS Short Interest Data AVTE Short Interest Data SLN Short Interest Data STOK Short Interest Data LYEL Short Interest Data NRIX Short Interest Data CALT Short Interest Data CVAC Short Interest Data GHRS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PHGUF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldShocking: One AI startup's revenue could surge 4,735%Manward PressThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily